Link to this page
Ontology of Drug Adverse Events
Last uploaded:
January 12, 2019
Jump to:
| Id | http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006710
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000006710
|
|---|---|
| Preferred Name | Interferon-alpha [Chemical/Ingredient] |
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label |
Interferon-alpha [Chemical/Ingredient]
|
|---|---|
| prefLabel |
Interferon-alpha [Chemical/Ingredient]
|
| NUI |
N0000006710
|
| Synonym |
Interferon, Leukocyte
alpha-Interferon
Interferon, Lymphoblast
Interferon Alfa
Interferon, Lymphoblastoid
Interferon, alpha
See more
See less
|
| code |
C23768
|
| prefixIRI |
NDF-RT:N0000006710
|
| RxNorm_CUI |
541
|
| subClassOf | |
| imported from | |
| MeSH_CUI |
M0025711
|
| MeSH_DUI |
D016898
|
| type | |
| MeSH_Name |
Interferon-alpha
|
| UMLS_CUI |
C0002199
|
| RxNorm_Name |
Interferon-alpha
|
| Display_Name |
Interferon-alpha
|
| MeSH_Definition |
One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells. In addition to antiviral activity, it activates NATURAL KILLER CELLS and B-LYMPHOCYTES, and down-regulates VASCULAR ENDOTHELIAL GROWTH FACTOR expression through PI-3 KINASE and MAPK KINASES signaling pathways.
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |